Clinical Trial Update: Dupilumab Effects Against Aeroallergen Challenge [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating dupilumab for effects against aeroallergen challenge in individuals with asthma; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Asthma, Allergic | Phase 2 | Status: RECRUITING